91�� News - RNA

D2R awards $400K to translate RNA research into real-world solutions

webfull — Wed, 25 Jun 2025 13:01:47 +0000

Montreal, June 25, 2025 – The DNA to RNA Initiative (D2R) at 91�� has awarded $400,000 to four projects that aim to bring RNA-based innovations closer to clinical and commercial reality, including vaccines and therapies for rare and infectious diseases.

Published: 25 June 2025

Panagiotis Prinos appointed as Director of Réseau DePTAQ

webfull — Fri, 11 Apr 2025 18:41:58 +0000

91��, the Institut de recherches cliniques de Montréal (IRCM) and Université de Sherbrooke, partners in the RNA Network for Therapy Development & Production (Réseau DePTAQ), are pleased to announce the appointment of Panagiotis (Takis) Prinos, PhD, as Director of Réseau DePTAQ.

Published: 11 April 2025

Call for proposals: Foundational and Research in Motion

webfull — Thu, 03 Apr 2025 18:32:43 +0000

D2R is pleased to launch the call for proposals for the Foundational and Research in Motion funding program.

This program integrates two previously separate funding programs - Foundational Projects and Research in Motion (RIM) - into a single, unified call. This program provides researchers with the flexibility to explore novel ideas and develop cutting-edge solutions that have the potential to lead to commercialization or clinical application.

Published: 3 April 2025

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

webfull — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – 91��’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Published: 26 March 2025

D2R awards over $6 million to support Core Platforms

webfull — Fri, 07 Feb 2025 14:37:46 +0000

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at 91�� and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.

Published: 7 February 2025

Lecture by Professor Sir Paul Nurse on May 1, 2024

webfull — Tue, 23 Apr 2024 19:24:50 +0000

As part of the Distinguished Professors Lecture Series by RI-MUHC, Professor Sir Paul Nurse, Chief Executive Officer of The Francis Crick Institute and Nobel Laureate in Physiology or Medicine will be giving two lectures on May 1 and May 2, 2024. Details in the posters above.

RSVP as soon as possible to manon.desrosiers [at] muhc.mcgill.ca as the places are limited.

Published: 23 April 2024